all - Opinion Summaries
Page 86 of 88
Showing Result 851 - 860 of 874
| Description | Date | Docket # |
|---|---|---|
SHIRE US INC. v. BARR LABS. INC.United States Third Circuit
Drugs & Biotech, Intellectual Property, Trade DressThe district court did not clearly err in finding that plaintiff had failed to show that its pill configuration and color were non-functional and thus... |
05/23/2003 | 02-3647 |
NAGEL v. TWIN LABS., INC.California Court of Appeal
Civil Procedure, Constitutional Law, Consumer Protection Law, Drugs & Biotech, False AdvertisingIn a suit for violations of California's unfair competition laws and the Consumer Legal Remedies Act, a product's ingredients do not satisfy the first... |
05/22/2003 | G030196 |
PHARM. RESEARCH & MFRS. OF AM. v. WALSHUnited States Supreme Court
Commercial Law, Constitutional Law, Drugs & Biotech, Government Benefits, RemediesA preliminary injunction preventing implementation of a state program reducing prescription drug prices for state residents was improper, where an... |
05/19/2003 | 01-188 |
INVITROGEN CORP. v. BIOCREST MFG., L.P.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentBecause the district court incorrectly construed the claims of a patent involving DNA technology, its summary judgment finding that defendant did not... |
05/07/2003 | 02-1207, 02-1260 |
IN RE VITAMINS ANTITRUST CLASS ACTIONSUnited States DC Circuit
Antitrust & Trade Regulation, Civil Procedure, Class Actions, Commercial Law, Drugs & BiotechDistrict judge did not abuse his discretion in finding that a party's neglect in failing to opt out of a settlement was excusable, thus an order... |
05/06/2003 | 02-7025 |
TEDFORD v. WARNER-LAMBERT CO.United States Fifth Circuit
Civil Procedure, Drugs & Biotech, Health LawIn a suit against the maker of Rezulin that was removed to federal court, the removal statute's (28 U.S.C. - 1446(b)) one-year limit on removal is... |
04/24/2003 | 02-10582 |
US v. ELLISUnited States Fourth Circuit
Administrative Law, Criminal Law & Procedure, Drugs & BiotechSufficient evidence showed that defendant's failure to register a kitchen laboratory operated for GHB manufacture was with an intent to defraud or... |
04/21/2003 | 01-4273 |
DESIANO v. WARNER-LAMBERT CO.United States Second Circuit
Civil Procedure, Class Actions, Drugs & Biotech, Health LawBecause plaintiffs' suit, for relief on behalf of all health benefit providers that paid for Rezulin, involves claims of damages that were caused... |
04/21/2003 | 01-9318 |
IN THE MATTER OF SYNTHROID MARKETING LITIG.United States Seventh Circuit
Attorney's Fees, Class Actions, Consumer Protection Law, Drugs & BiotechFor each band of recovery after a class action alleging consumer fraud by a pharmaceutical company, consumer class counsel should recover at least as... |
04/15/2003 | 02-2398/2519 |
BRISTOL-MYERS SQUIBB CO. v. RHONE-POULENC RORER, INC.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentThe district court's holding that defendant committed inequitable conduct in obtaining a patent, involving a semi-synthesis of taxol, a cancer... |
04/15/2003 | 02-1280, 02-1281 |
Results 851 to 860 of 874